Karolinska Development AB has appointed Fredrik Järrsten as Chief Financial Officer.
Mr Järrsten will replace Christian Tange who, after 4 years with Karolinska Development, has decided to pursue other opportunities.
Mr Tange will remain with the company until after Mr Järrsten’s arrival to ensure a smooth and orderly handover period.
Fredrik Järrsten is an experienced financial and business development executive.
He will join Karolinska Development from Bactiguard Holding AB, a public Swedish medtech company where he is Chief Financial Officer and Business Development director.
At Bactiguard he, among other things, led the company’s IPO on Nasdaq Stockholm in June 2014. Prior to joining Bactiguard in 2014, Fredrik was Director Business Development, including M&A, at Aleris, one of Scandinavia’s leading private healthcare companies.
While at Aleris, Fredrik concluded 30 acquisitions and two disposals, which contributed significantly to the company’s growth. Before joining Aleris in 2006, Fredrik was an Investment Manager at the private equity company, Litorina Kapital for 7 years, where he was on the boards of six investee companies.
Viktor Drvota, CEO, comments: “I am very pleased that Fredrik has decided to join Karolinska Development. His broad financial knowledge both as a CFO and an investor, as well as his significant business development and M&A experience, will be vital as we work to generate exits from our investee companies."
"We believe we have multiple potential exit opportunities in the next 12 months which, if achieved, would crystallise significant value for our shareholders."
"I would also like to thank Christian for his hard work during the last 4 years, a period of enormous change for Karolinska Development, and I wish him success with his future plans. I am pleased that he has agreed to work alongside Fredrik to ensure a smooth transition period.”
